Recent developments indicate that pharmaceutical companies are implementing coupon programs aimed at lowering the expenses of telehealth consultations.
These initiatives are designed to facilitate access to healthcare by allowing clinicians to prescribe medications during virtual visits.
As the healthcare landscape evolves, such strategies may play a significant role in bridging the gap between patients and necessary treatments.